Published September 2021 | Version v1
Journal article

Plumbojarosite formation in contaminated soil to mitigate childhood exposure to lead, arsenic and antimony

  • 1. University of South Australia, Future Industries Institute, SA (Australia)
  • 2. South Australian Health and Medical Research Institute, Adelaide, SA (Australia)
  • 3. United States Environmental Protection Agency, Center for Environmental Solutions and Emergency Response, Land Remediation and Technology Division, Cincinnati, Ohio (United States)

Description

Highlights: • Novel microwave assisted lead (Pb) immobilizing method developed using Fe2(SO4)3. • USEPA Method 1340 showed that Pb bioaccessibility was reduced by 77–97%. • Pb accumulation in femur, liver and kidneys was reduced between 73% and 93% in mice. • XAS showed a 72–100% conversion of Pb to plumbojarosite in treated soil. • This technique also reduced arsenic and antimony bioavailability during treatment. In this study, a novel method for lead (Pb) immobilization was developed in contaminated soils using iron (III) (Fe3+) in conjunction with 0.05 M H2SO4. During method optimization, a range of microwave treatment times, solid to solution ratios, and Fe2(SO4)3/H2SO4 concentrations were assessed using a mining/smelting impacted soil (BHK2, Pb: 3031 mg/kg), followed by treatment of additional Pb contaminated soils (PP, Pb: 1506 mg/kg, G10, Pb: 2454 mg/kg and SoFC-1, Pb: 6340 mg/kg) using the optimized method. Pb bioaccessibility was assessed using USEPA Method 1340, with Pb speciation determined by X-ray Absorption (XAS) spectroscopy. Treatment efficacy was also validated using an in vivo mouse assay, where Pb accumulation in femur, kidney and liver was assessed to confirm in vitro bioaccessibility outcomes. Results showed that Pb bioaccessibility could be reduced by 77.4–97.0% following treatment of soil with Fe2(SO4)3 (0.4–1.0 M), H2SO4 (0.05 M) at 150 °C for 60 min in a closed microwave system. Results of bioavailability assessment demonstrated treatment effect ratio of 0.06–0.07 in femur, 0.06–0.27 in kidney and 0.06–0.11 in liver (bioavailability reduction between 73% and 93%). Formation of plumbojarosite in treated soils was confirmed by XAS analysis.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.jhazmat.2021.126312

Additional details

Identifiers

DOI
10.1016/j.jhazmat.2021.126312;
PII
S0304389421012760;

Publishing Information

Journal Title
Journal of Hazardous Materials
Journal Volume
418
Journal Page Range
vp.
ISSN
0304-3894
CODEN
JHMAD9

Optional Information

Copyright
Copyright (c) 2021 Elsevier B.V. All rights reserved.